Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma.
about
Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity.Efficacy and safety of gemcitabine-based chemotherapies in biliary tract cancer: a meta-analysis.Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic ReviewChemotherapy for advanced biliary tract carcinoma: A meta-analysis of randomized controlled trials.Current status of chemotherapy for the treatment of advanced biliary tract cancer.S-1-based regimens and the risk of oral and gastrointestinal mucosal injury: a meta-analysis with comparison to other fluoropyrimidines.Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer.Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy.The efficacy and safety of different pharmacological interventions for patients with advanced biliary tract cancer: A network meta-analysis.Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer.CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy.
P2860
Q33428545-B8C62C8E-829B-4F8F-8116-246C0050B21AQ34627947-34D91880-4334-4EF7-9734-176DA8617D4CQ35535548-B5C3542B-DC90-45E8-8E2A-841E0098FC3EQ35871195-3B5833CC-7940-431C-8627-D29E3780770AQ36107068-F00DAA38-5142-4E76-9CE8-261B08ADD6CEQ37138732-ED55F549-62A0-4CF7-84C4-19DC1FD7B95EQ38619215-7150AD2B-A53B-4C40-B9A7-4899CF74AF70Q40524551-2431CF3A-6880-446B-BC10-1B71A01F6466Q40824695-EBD4ACE7-1EFF-41DB-A579-A59C48053A83Q47139810-840D5BCD-BDD7-4547-A9E2-DA1EDCD5D8B2Q50609881-DCB910A7-78A1-4384-B41E-23BA3246C76DQ50940059-0ADFE43B-80CA-4EF9-9D2B-21393DA12F43
P2860
Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Randomized phase II trial of S ...... biliary tract adenocarcinoma.
@ast
Randomized phase II trial of S ...... biliary tract adenocarcinoma.
@en
type
label
Randomized phase II trial of S ...... biliary tract adenocarcinoma.
@ast
Randomized phase II trial of S ...... biliary tract adenocarcinoma.
@en
prefLabel
Randomized phase II trial of S ...... biliary tract adenocarcinoma.
@ast
Randomized phase II trial of S ...... biliary tract adenocarcinoma.
@en
P2093
P2860
P1433
P1476
Randomized phase II trial of S ...... biliary tract adenocarcinoma.
@en
P2093
Do Hyun Park
Dong Wan Seo
Jae-Lyun Lee
Myoung Joo Kang
Myung-Hwan Kim
Sang Soo Lee
Sung Koo Lee
Sung Sook Lee
Tae Won Kim
P2860
P304
P356
10.3109/0284186X.2012.682628
P577
2012-05-06T00:00:00Z